335 related articles for article (PubMed ID: 25325874)
1. Side-effects of anti-inflammatory therapy in uveitis.
Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory Therapy in Uveitis.
Tomkins-Netzer O; Talat L; Ismetova F; Samy A; Lightman S
Dev Ophthalmol; 2016; 55():265-75. PubMed ID: 26501368
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of uveitis.
Lee FF; Foster CS
Expert Opin Pharmacother; 2010 May; 11(7):1135-46. PubMed ID: 20367272
[TBL] [Abstract][Full Text] [Related]
4. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone for ocular inflammation.
Saraiya NV; Goldstein DA
Expert Opin Pharmacother; 2011 May; 12(7):1127-31. PubMed ID: 21457057
[TBL] [Abstract][Full Text] [Related]
7. Road to remission: a comprehensive review of therapy in uveitis.
Siddique SS; Shah R; Suelves AM; Foster CS
Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection therapy in the treatment of noninfectious uveitis.
Modorati G; Miserocchi E
Dev Ophthalmol; 2012; 51():110-21. PubMed ID: 22517209
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for childhood noninfectious chronic uveitis: an update.
Cantarini L; Simonini G; Frediani B; Pagnini I; Galeazzi M; Cimaz R
Expert Opin Investig Drugs; 2012 Jan; 21(1):1-6. PubMed ID: 22074394
[TBL] [Abstract][Full Text] [Related]
10. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
Zhao M; Wang H; Jiao X; Wei WB
Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.
Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
Expert Opin Biol Ther; 2014 Nov; 14(11):1651-66. PubMed ID: 25226284
[TBL] [Abstract][Full Text] [Related]
12. The use of intraocular corticosteroids.
Kiernan DF; Mieler WF
Expert Opin Pharmacother; 2009 Oct; 10(15):2511-25. PubMed ID: 19761356
[TBL] [Abstract][Full Text] [Related]
13. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.
Lima BR; Nussenblatt RB; Sen HN
Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):875-82. PubMed ID: 23521173
[TBL] [Abstract][Full Text] [Related]
15. Posterior Uveitis.
Uy HS; Yu-Keh E; Chan PS
Dev Ophthalmol; 2016; 55():163-6. PubMed ID: 26502276
[TBL] [Abstract][Full Text] [Related]
16. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
17. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
18. Histoplasmosis Following Systemic Immunomodulatory Therapy for Ocular Inflammation.
Starr MR; Smith WM
Am J Ophthalmol; 2019 Feb; 198():88-96. PubMed ID: 30308204
[TBL] [Abstract][Full Text] [Related]
19. Systemic immunosuppressive therapies for uveitis in developing countries.
Agrawal H; Doan H; Pham B; Khosla A; Babu M; McCluskey P; Nguyen QD; Sangwan V; Reddy S; Sawhney S; Tyagi M
Indian J Ophthalmol; 2020 Sep; 68(9):1852-1862. PubMed ID: 32823402
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
Suhler EB; Lowder CY; Goldstein DA; Giles T; Lauer AK; Kurz PA; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Tessler HH; Smith JR; Rosenbaum JT
Br J Ophthalmol; 2013 Apr; 97(4):481-6. PubMed ID: 23376607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
